Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT05873361

Postoperative Follow-up of Asymptomatic Papillary Microcarcinomas on Patient Survival

This is a study assessing the interest of post-operative follow-up of asymptomatic papillary microcarcinomas. Today, this post-operative follow-up represents an economic cost and is a source of anxiety for patients.

The aim of this study is to determine the global survival of patients with asymptomatic papillary microcarcinoma to assess the interest of a post-operative ultrasound and/or biological follow-up.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Key information

Conditions

Papillary Carcinoma Carcinoma Carcinoma, Papillary Neoplasms Neoplasms by Histologic Type Neoplasms, Glandular and Epithelial Neoplasms, Squamous Cell

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

UHToulouse

Toulouse, 31059, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients with uni or multifocal papillary microcarcinoma (cumulative size of foci <10mm) asymptomatic or not and who underwent partial or total thyroidectomy from 2012 to 2017.
  • Non opposition patient
  • Affiliation to a social security scheme

Exclusion criteria

  • Lesion crossing the thyroid capsule, or cervical lymph node involvement clinical or histological cervical lymph node involvement.
  • Patient under guardianship, curators or safeguard of justice

Treatment and study plan

Questionnaire

Other

The questionnaire is about hypocalcemia, dysphonia and anxiety. It will be carried out by phone call for 10 minutes

Primary outcomes

  1. Overall survival

    Time frame: 10 years

    Review of medical record

Secondary outcomes

  1. Disease control rate

    Time frame: 10 years

    No recurrence clinically detected or by additional examen

  2. Surgical complications rate

    Time frame: 10 years

    Dysphonia and hypocalcemia

  3. Detection of recurrence rate

    Time frame: 10 years

    Recurrence detection by additional examen

  4. Recovery surgical or iratherapie recovery rate

    Time frame: 10 years

    Anatomopathologic analysis

  5. Anxiety evaluation

    Time frame: 1 month

    Likert scale

  6. Prognostics survival criteria

    Time frame: 1 month

    Age during surgical

Sponsors and collaborators

Lead sponsor

University Hospital, Toulouse

Other

Registry information

Official study title

Interest of Postoperative Follow-up of Asymptomatic Papillary Microcarcinomas on Patient Survival

Acronym: MIPTHYS

Important dates

Study start
2023
Primary completion
2027
Study completion
2027
First posted
May 24, 2023
Registry last updated
Jun 22, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.